Lamellarin D: A novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux

Cancer Letters

Volumn 221, Issue 2, 2005, Pages 165-175

  Vanhuyse, Marie ^a   Kluza, Jérôme ^a   Tardy, Christèle ^a   Otero, Gabriel ^b   Cuevas, Carmen ^b   Bailly, Christian ^a   Lansiaux, Amélie ^a  

^a CENTRE OSCAR LAMBRET   (France)

^b PHARMAMAR S A   (Spain)

Author keywords

Apoptosis; Camptothecin; Lamellarin D; Mitochondria; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; CALCEIN; CAMPTOTHECIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; LAMELLARIN D; QUININE; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL MEMBRANE DEPOLARIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE MUTATION; MITOCHONDRIAL MEMBRANE; MITOSIS INDEX; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL;

EID: 16244384633     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.09.022     Document Type: Article

References (33)

1. R.J. Andersen, D.J. Faulkner, C.H. He, G.D. Van Duyne, and J. Clardy Metabolites of the marine prosobranch mollusk Lamellaria sp J. Am. Chem. Soc. 107 1985 5492 5495
2. R.H. Davis, A.R. Carroll, G.K. Pierens, and R.J. Quinn New lamellarin alkaloids from the Australian ascidian, Didemnum chartaceum J. Nat. Prod. 62 1999 419 424
3. C. Bailly Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloids Curr. Med. Chem. Anti-Cancer Agents 4 2004 363 387
4. M. Facompré, C. Tardy, C. Bal-Mayeu, P. Colson, C. Perez, and I. Manzanares Lamellarin D: a novel potent inhibitor of topoisomerase I Cancer Res. 63 2003 7392 7399
5. C. Tardy, M. Facompré, M. Laine, B. Baldeyrou, D. Garcia-Gravalos, and A. Francesch Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues Bioorg. Med. Chem. 12 2004 1697 1712
6. M.G. Banwell, and D. Hockless Convergent total synthesis of lamellarin K Chem. Commun. 23 1997 2259 2260
7. J. Madelaine, S. Prost, A. Naudin, G. Riou, F. Lavelle, and J.F. Riou Sequential modifications of topoisomerase I activity in a camptothecin resistant cell line established by progressive adaptation Biochem. Pharmacol. 45 1993 339 348
8. G.N. Papanicolaou A new procedure for staining vaginal smears Science 95 1942 438 439
9. J. Kluza, A. Lansiaux, N. Wattez, C. Mahieu, N. Osheroff, and C. Bailly Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103 Cancer Res. 60 2000 4077 4084
10. J. Kluza, A. Lansiaux, N. Wattez, M.P. Hildebrand, S. Léonce, and A. Pierré Induction of apoptosis in HL-60 leukemia and B16 melanoma cells by the acronycine derivative S23906-1 Biochem. Pharmacol. 63 2000 1443 1452
11. B. Pilch, E. Allemand, M. Facompré, C. Bailly, J.F. Riou, J. Soret, and J. Tazi Specific inhibition of SR splicing factors phosphorylation, spliceosome assembly and splicing by the anti-tumor drug NB506 Cancer Res. 61 2001 6876 6884
12. D. Kessel, W.T. Beck, D. Kukuruga, and V. Schulz Characterization of multidrug resistance by fluorescent dyes Cancer Res. 51 1991 4665 4670
13. Z. Hollo, L. Homolya, C.W. Davis, and B. Sarkadi Calcein accumulation as a fluorometric functional assay of the multidrug transporter Biochim. Biophys. Acta 1191 1994 384 388
14. L. Homolya, Z. Hollo, U.A. Germann, I. Pastan, M.M. Gottesman, and B. Sarkadi Fluorescent cellular indicators are extruded by the multidrug resistance protein J. Biol. Chem. 268 1993 21493 21496
15. N. Feller, H.J. Broxterman, D.C. Wahrer, and H.M. Pinedo ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion Fed. Eur. Biochem. Soc. Lett. 368 1995 385 388
16. T. Tsuruo, H. Iida, S. Tsukagoshi, and Y. Sakurai Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Res. 41 1981 1967 1972
17. J.L. Weaver, G. Szabo Jr., P.S. Pine, M.M. Gottesman, S. Goldenberg, and A. Aszalos The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter Int. J. Cancer 54 1993 456 461
18. T. Litman, T.E. Druley, W.D. Stein, and S.E. Bates From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance Cell. Mol. Life Sci. 58 2001 931 959
19. J. Robert, and C. Jarry Multidrug resistance reversal agents J. Med. Chem. 46 2003 4805 4817
20. H.S. Mulder, H. Dekker, H.M. Pinedo, and J. Lankelma The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity Biochem. Pharmacol. 50 1995 967 974
21. S. Soues, F. Laval, and J.Y. Charcosset Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells Br. J. Cancer 71 1995 489 497
22. W. Berger, L. Elbling, E. Hauptmann, and M. Micksche Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells Int. J. Cancer 73 1997 84 93
23. O. Legrand, G. Simonin, A. Beauchamp-Nicoud, R. Zittoun, and J.P. Marie Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia Blood 94 1999 1046 1056
24. K.O. Hamilton, E. Topp, I. Makagiansar, T. Siahaan, M. Yazdanian, and K.L. Audus Multidrug resistance-associated protein-1 functional activity in Calu-3 cells J. Pharmacol. Exp. Ther. 298 2001 1199 1205
25. D. Chauvier, G. Kegelaer, H. Morjani, and M. Manfait Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecin J. Pharm. Sci. 91 2002 1765 1775
26. H.S. Kim, Y.D. Min, and C.H. Choi Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid Biochem. Biophys. Res. Commun. 283 2001 64 71
27. S.A. Ben-Sasson, Y. Sherman, and Y. Gavrieli Identification of dying cells-in situ staining Methods Cell. Biol. 46 1995 29 39
28. 6(3) or rhodamine 123, is a reliable fluorescent probe to assess ΔΨ changes in intact cells: implications for studies on mitochondrial functionality during apoptosis Fed. Eur. Biochem. Soc. Lett. 411 1997 77 82
29. G. Bradley, P.F. Juranka, and V. Ling Mechanism of multidrug resistance Biochim. Biophys. Acta 948 1998 87 128
30. A.R. Quesada, M.D. Garcia Gravalos, and J.L. Fernandez Puentes Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein Br. J. Cancer 74 1996 677 682
31. D.L. Boger, C.W. Boyce, M.A. Labroli, C.A. Sehon, and Q. Jin Total syntheses of ningalin A, lamellarin O, lukaniol A, and permethyl storniamide A utilizing heterocyclic azadiene Diels-Alder reactions J. Am. Chem. Soc. 121 1999 54 62
32. M. Facompré, N. Wattez, J. Kluza, A. Lansiaux, and C. Bailly Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide Mol. Cell. Biol. Res. Commun. 4 2000 37 42
33. M. Facompré, J.F. Goossens, and C. Bailly Apoptotic response of HL-60 human leukemia cells to the antitumor drug NB-506 inhibitor of topoisomerase I Biochem. Pharmacol. 61 2001 299 310